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Abstract
The transcription factor Interferon Regulatory Factor 5 (IRF-5) has been shown to be involved in the induction of
proinflammatory cytokines in response to viral infections and TLR activation and to play an essential role in the innate
inflammatory response. In this study, we used the experimental model of visceral leishmaniasis to investigate the role of IRF-
5 in the generation of Th1 responses and in the formation of Th1-type liver granulomas in Leishmania donovani infected
mice. We show that TLR7-mediated activation of IRF-5 is essential for the development of Th1 responses to L. donovani in
the spleen during chronic infection. We also demonstrate that IRF-5 deficiency leads to the incapacity to control L. donovani
infection in the liver and to the formation of smaller granulomas. Granulomas in Irf5
-/- mice are characterized by an
increased IL-4 and IL-10 response and concomitant low iNOS expression. Collectively, these results identify IRF-5 as a critical
molecular switch for the development of Th1 immune responses following L. donovani infections and reveal an indirect role
of IRF-5 in the regulation of iNOS expression.
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Introduction
The protozoan parasite Leishmania donovani is the causative agent
of visceral leishmaniasis (VL), a chronic life threatening disease if
untreated. In the experimental model of VL, the two main target
organs are the liver and the spleen [1]. While the spleen stays
chronically infected, infection in the liver is self-resolving within 6-
8 weeks due to the development of a Th1-dominated granuloma-
tous response, which is characterized by high IFNc production.
This response is induced by IL-12 secreted by dendritic cells (DC)
[2,3,4] and is crucial for parasite control and disease resolution in
the liver, together with TNFa production and expression of
inducible nitric oxide synthase (iNOS) by macrophages [1].
Studies using Myd88
-/- mice have highlighted the importance of
toll like receptors (TLRs) in the induction of IL-12 production by
DC and the development of Th1 immune responses in Leishmania
infection [5]. More recently, TLR9 has been shown to be required
for IL-12 production by DC in a model of cutaneous leishmaniasis
[6,7] and also in Trypanosoma cruzi infected mice [8]. However, in
contrast to T. cruzi infections, TLR9 deficiency in mice infected
with L. major did not prevent the development of Th1 responses
and only resulted in a transient disease exacerbation [6,9]. As
MyD88
-/- mice are highly susceptible to Leishmania infection [5],
this suggests that in addition to TLR9, other TLRs as well as IL-1
and IL-18 may also be involved in the generation of Th1 responses
and in the induction of host protective immunity. Since Leishmania
parasites reside in the phagolysosomes of the host cells, other
endosomally localized TLRs, such as TLR 7 and 8 could be
involved in the recognition of this pathogen [10,11].
Interferon Regulatory Factor 5 (IRF-5) has been shown to be
involved in the transcriptional activation of both Type I IFN genes
and genes encoding key proinflammatory cytokines such as IL-12,
TNFa and IL-6 [12,13,14,15]. This transcription factor can be
activated by TLR7 and TLR9 via the MyD88 signaling pathway
and/or directly by viral infections and Type I interferon [16]. In
vivo, IRF-5 has been shown to play a role in the innate antiviral
immune response. Indeed, lack of IRF-5 expression in genetically
modified Irf5
-/- mice resulted in attenuation of Type I IFN, TNFa
and IL-6 production in response to viral infection [13,17,18].
However, the antiviral effect of IRF-5 deficiency appeared to be
cell type specific and mainly affected DCs and plasmacytoid DCs
(pDCs), rather than macrophages [16,17]. More recently, IRF-5
was also shown to cooperate with, among others, NOD2 and
TBK1 in triggering expression of Type I interferon in response to
Mycobacterium tuberculosis [19].
The aim of this study was to examine whether IRF-5 also plays
a role in the regulation of the immune response to parasitic
infections. Here we demonstrate that IRF-5 deficiency results in
severe impairment in the development of Th1 immune responses
following L. donovani infection. Moreover, Irf5
-/- mice failed to
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the liver, demonstrating a vital role for IRF-5 in the induction of
the anti-parasitic response.
Results
IRF-5 is required for disease control in the liver
The transcription factor IRF-5 is an important downstream
regulator of the TLR/MyD88 signaling pathway and is involved
in the induction of several key proinflammatory cytokines
[13,16,17]. As TLRs have been implicated in the recognition of
Leishmania parasites [5,6,7,20,21,22,23], we first wanted to assess
whether IRF-5 was at all involved in the generation of protective
immunity against L. donovani. Hence, we infected wild type (WT)
and Irf5
-/- mice and monitored the course of infection at several
time points. We observed similar parasite burdens for WT and
Irf5
-/- mice in the spleen (Fig. 1A). In contrast, the disease was
exacerbated in the livers of Irf5
-/- mice, with a parasite burden of
approximately two times higher at d14 pi and almost 4-fold higher
than in the WT controls by d28 pi (Fig. 1B). These data suggest
that the requirements for IRF-5 in the immune response to L.
donovani are strictly organ specific, at least until day 28p.i..
IRF-5 deficiency results in defective Th1 responses
As IFNc-producing CD4
+ T helper cells are crucial for the
control of L. donovani infection in the liver, we next investigated
whether these responses were being generated in Irf5
-/- mice.
IFNc–producing CD4
+ T cells were already detected at d14 of
infection in both the liver and spleen of WT mice, although still at
low frequency. The frequency of IFNc
+ CD4
+ T cells increased in
the later stages of infection and by d28 pi, 39.1% of CD4
+ T cells
in the liver (Fig. 2A and B) and 7.6% in the spleen (Fig. 2C and D)
of WT mice were producing IFNc. In marked contrast, the
generation of IFNc-producing CD4
+ T cells was significantly
impaired in the livers of Irf5
-/- mice (Fig. 2A), where only 13.2% of
CD4
+ T cells were IFNc
+ at d28 (a 60% reduction), and in the
spleen (Fig. 2C), where only 2.8% of CD4
+ T cells were found to
be secreting IFNc (a 60% reduction compared to WT controls).
Interestingly, at day 14p.i., the frequency of IFNc
+ CD4
+ T-cells
in the liver and spleens of Irf5
-/- mice was comparable, if not better
than in WT mice (Fig. 2). This suggests that initially Th1 responses
are being generated in the absence of IRF-5, however this
transcription factor is essential for the maintenance and further
expansion of Th1 responses.
Irf5
-/- mice fail to develop Th1-type granulomas
In order to determine whether the defective generation of Th1
responses detected in Irf5
-/- mice had an impact on the Th1-type
granuloma formation normally observed in the livers of L. donovani
infected WT mice [1], we proceeded to analyze H&E stained
sections of livers from WT and Irf5
-/- mice. Despite an
approximately 4-fold higher liver parasite burden in Irf5
-/- mice
(Fig. 1B), the number of granulomas/inflammatory foci observed
in Irf5
-/- mice at d28 p.i. was reduced approximately by 77%
compared with WT mice (406.7615.7 granuloma/100 micro-
scopic fields in WT mice vs. 92638 granuloma/100 microscopic
fields in Irf5
-/- mice). A closer histological analysis also revealed
that the granulomas in Irf5
-/- mice were smaller in size and had a
different cellular composition, characterized by a marked
infiltration of polymorphonucleated cells that were identified as
neutrophils (Fig. 3A). Neutrophils were also observed at higher
frequencies in the spleens of infected Irf5
-/- mice compared to WT
controls (Fig. S1 A and B). Increased neutrophil infiltration
correlated with higher mRNA levels for CXCL1, a chemokine
receptor known for its neutrophil chemoactractant activity, in the
liver (day 14 p.i. only) and spleens of Irf5
-/- compared to WT mice
(Fig. 3 B and C). Of additional interest is the observation that the
mononuclear cell infiltrates in the livers of Irf5
-/- mice were
significantly reduced at day 28 p.i. compared to WT mice (data
not shown and Fig. 2B). Moreover, in Irf5
-/- mice we could not
observe any splenomegaly, which is a typical symptom of VL in
WT mice (Fig. 3D). These results suggest that IRF-5 is an essential
factor in the maintenance of the inflammatory responses generated
during L. donovani infection. IL-23 has recently been shown to be
involved in immune cell homing to infected target cells [24], hence
we also assessed whether this cytokine was expressed at different
levels in the livers of Irf5
-/- mice. To our surprise, IL-23 p19 was
slightly upregulated in Irf5
-/- mice at day 14 p.i., but was induced
at similar levels at later stages of infection in both WT and Irf5
-/-
mice (Fig. 3E).
Since Irf5
-/- granulomas were not the typical Th1-type
granulomas which develop in infected WT mice and, unlike WT
Figure 1. Leishmania donovani infection in Irf5
-/- mice. Parasite
burdens in the spleen (A) and liver (B) were determined for infected WT
and Irf5
-/- mice at d14 and d28 pi as described. Data shown is the mean
6 SEM and is representative of two independent experiments.
* denotes p,0.05 and ** denotes p,0.01.
doi:10.1371/journal.ppat.1001246.g001
Author Summary
Leishmania donovani is a parasite that currently infects 12
million people around the world. In order to better
understand why this parasite causes incurable disease
we chose to investigate how the immune system sees L.
donovani. The immune system sees infecting organisms by
the recognition of molecules that are specifically expressed
by pathogens. This is done by a family of receptors
expressed by cells called Toll Like Receptors (TLRs). When
TLRs recognize a pathogen it leads to a molecular chain
reaction within the cell resulting in the release of
cytokines. Interferon Regulatory Factors (IRFs) are a very
important part of this signaling chain. The protein we have
studied, IRF-5, has been identified as having a key role in
inducing pro-inflammatory cytokines following the recog-
nition of viruses by TLRs. However, whether it plays a role
in the immune response to parasitic disease has not yet
been examined. In this study we infected mice deficient of
IRF-5 with L. donovani and demonstrate for the first time
that IRF-5 is essential to develop a protective response
against this parasite. These results are important as they
help us to understand the molecular mechanisms required
for an immune response to fight L. donovani.
Role of IRF5 in the Immunity to Leishmania
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-/- mice failed to eliminate the parasites, we next
examined the cytokine environment in the livers of both groups of
mice. IRF-5 deficiency resulted not only in a very weak IFNc
responses (Fig. 2B), but also in a significantly higher expression of
IL-4 and IL-10 mRNA compared to WT mice (Fig. 3 F).
Interestingly, the differences in cytokine mRNA levels were
observed only at d28 pi but not during the first 2 weeks of
infection. Surprisingly, however, we did not observe any significant
differences in the relative levels of TNFa (Fig. 3E), IL-13, or IL-5
(data not shown) between the two groups. Moreover, Irf5
-/- and
WT mice showed comparable frequencies of IL-10- and IL-17-
producing CD4
+ T cells at d28 pi (data not shown). Taken
together, these data suggest that unlike in WT mice, L. donovani
infection in Irf5
-/- mice induces a very small inflammatory
infiltration in the liver and results in the generation of an IL-4-
dominated response, resulting in a failure to control parasite
growth.
Attenuation of IL-12p35 expression in L. donovani
infected Irf5
-/- mice
It is well established that the production of IL-12 by DCs is
crucial for the development of Th1 cells [25], although an IL-12-
independent mechanism for the induction Th1 responses has also
been described [26]. A study in Myd88
-/- mice infected with L.
major has highlighted the importance of TLRs, IL-1 and/or IL-18
in the induction of IL-12 and the generation of Th1 responses;
MyD88 deficiency also resulted in complete abrogation of IFNc
production by CD4
+ T cells and an inability to control infection
[5]. More recently, TLR9 activation has been shown to play a
crucial role in the induction of IL-12 secretion by DCs following T.
cruzi and Leishmania infections [6,7]. As the development of IFNc-
producing CD4
+ T cell in L. donovani infected mice was shown to
depend upon IL-12 production by conventional CD11c
hi DC
(cDC), we examined whether IRF-5 deficient DC were able to
produce IL-12 in vivo following L. donovani infection. In agreement
with the literature [27], we detected a moderate increase in IL-
12p35 mRNA levels in cDCs isolated from infected WT mice
(Fig. 4). However, induction of IL-12p35 was not detected in IRF-
5 deficient cDCs. In contrast, IL-12p40 mRNA expression was
induced in cDCs of Irf5
-/- at similar levels as in cDC of WT mice
(data not shown). Since the p40 component of IL-12 is shared with
IL-23, the upregulation of p40 may be caused by an increased
expression of IL-23 (s. Fig. 3E).
IRF-5 indirectly regulates iNOS expression
Inducible nitric oxide synthase (iNOS) is a key enzyme involved
in the production of nitric oxide (NO), which has direct microbial
toxicity and is also involved in the regulation of cytokine gene
Figure 2. Irf5
-/- mice have a defective Th1 response. The percentage of CD4
+ T cells producing IFNc as a response to L. donovani infection in the
liver (A) and the spleen (C) of WT and Irf5
-/- mice was determined by intracellular flow cytometry. Representative scatter plots from WT and Irf5
-/- mice
infected with L. donovani showing IFNc production by CD4
+ T cells in the liver (B) and spleen (D) at different times p.i.. Data is shown as the mean 6
SEM. Flow cytometry data is representative of two independent experiments. * denotes p,0.05 and ** denotes p,0.01.
doi:10.1371/journal.ppat.1001246.g002
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by classically activated macrophages upon triggering of IFN and
TLR pathways that enhance the expression of iNOS [28,29,30].
In the absence of a strong IFNc response and the presence of an
IL-4 dominated immune response in infected Irf5
-/- mice, we were
curious as to whether iNOS (NOS2) was still able to be induced at
all in Irf5
-/- mice. To our surprise, we found no difference in the
induction of iNOS mRNA in the livers of Irf5
-/- and WT mice
(Fig. 5A). As the absence of IRF-5 appeared to be leading to a
Th2-like state in the liver, we were also interested in determining
whether markers for the alternative activation of macrophages
were being induced in mice deficient in IRF-5. Using real time
PCR we only found a slight increase in the induction of Arg1
(Fig. 5B) and Fizz1 (Fig. 5C) in the livers of infected Irf5
-/- mice
compared to WT mice.
Since iNOS mRNA levels were similar in Irf5
-/- and WT mice,
we next investigated whether this message was being translated
into protein. iNOS protein was expressed in the livers of infected
WT mice, mainly in granulomas (Fig. 5D). In contrast, it was not
detected in infected Irf5
-/- mice at any time point after infection
(Fig. 5D).
To determine whether IRF-5 directly regulates transcription of
iNOS, we used a luciferase reporter assay, where luciferase was
under the control of the NOS2 promoter cotransfected with
MyD88 and/or IRF-5 expression plasmids. As shown in Figure 5E
and in agreement with the literature [28,30], MyD88 expression
induced a 7.86 fold increase in luciferase activity. In contrast, IRF-
5 failed to induce luciferase activity, suggesting that overexpression
of inactivated IRF-5 alone does not stimulate the transcriptional
activity of the NOS2 promoter. Co- transfection with both MyD88
and IRF-5 expression plasmids resulted only in a slight increase in
the transcriptional activity of the NOS2 promoter. Taken together,
these results indicate that IRF-5 does not stimulate transcription of
iNOS but may play a role to indirectly regulate the iNOS response
to L. donovani at the posttranscriptional level.
We next infected WT and Irf5
-/- bone marrow-derived
macrophages in vitro with L. donovani and monitored the iNOS
mRNA expression by real time PCR. In agreement with the results
shown in Fig. 5E, IRF-5 deficiency did not affect the iNOS mRNA
level (Fig. 5F) or the NO production (Fig. S2 A) following L.
donovani infection, suggesting that IRF-5 does not directly induce
transcription of iNOS. However, when we stimulated WT and
Figure 3. Irf5
-/- mice do not develop Th1-type granulomas. (A)
Representative granulomas from H&E stained liver sections at d28 pi in
WT and Irf5
-/- mice. Pictures were taken at the indicated magnifications
and arrows indicate the presence of neutrophils in the granulomas. (B,
C) Real time PCR analysis of the livers (B) and spleen (C) measuring
mRNA for CXCL1. (D) Spleen weights at d14 and d28 pi. The body
weight of C57BL/6 WT and Irf5
-/- mice was comparable. (E) Real time
PCR analysis of the livers from infected mice measuring mRNA for IL-23
p19. (F) Real time PCR measurement of cytokine mRNA in the livers of
infected mice indicates a skewing toward a Th2 environment. All data is
presented as the mean 6 SEM combined from two independent
experiments. * denotes p,0.05 and ** denotes p,0.01.
doi:10.1371/journal.ppat.1001246.g003
Figure 4. L. donovani fails to induce IL-12p35 expression in Irf5
-/-
mice. WT and Irf5
-/- mice were infected with L. donovani amistigotes. At
5 h, splenic cDCs were purified. IL-12p35 mRNA was detected by real
time PCR. Data is shown for n=3 WT samples and n=4 Irf5
-/- samples.
* denotes p,0.05 and ** denotes p,0.01.
doi:10.1371/journal.ppat.1001246.g004
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-/- macrophages with LPS, we could see a marked decrease in
both iNOS mRNA transcipts (Fig. 5F) and NO production (Fig.
S2 A). This was possibly caused by a defective pro-inflammatory
response in Irf5
-/- macrophages (Fig. S2 B). This defect was not
observed in Irf5
-/- macrophages infected with L. donovani (Fig. S2
B), suggesting that the induction of pro-inflammatory cytokines in
macrophages infected in vitro with L. donovani is IRF-5
independent. This data implies that the inflammatory signals
Figure 5. IRF-5 deficiency results in defective iNOS production. Real time PCR analysis of livers from infected mice measuring mRNA for iNOS
(A), arginase1 (B) and Fizz1 (C). All data is presented as the mean 6 SEM combined from two independent experiments, n=6-9 mice per group. (D)
iNOS protein in the liver was examined by immunohistochemistry. (E) Induction of the NOS2 promoter by MyD88 and IRF-5 was measured by
luciferase assay. Data shown is fold induction of the promoter compared to promoter only controls and represents the mean6 SEM for triplicate
samples from 2 independent experiments. * denotes p,0.05 and ** denotes p,0.01. (F) Real time PCR analysis of iNOS mRNA in WT and Irf5-/-
macrophages stimulated with LPS and/or L.donovani amastigotes. Data is shown for n=3.
doi:10.1371/journal.ppat.1001246.g005
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of iNOS. Thus it is possible that the defective pro-inflammatory
response observed in L. donovani infected Irf5
-/- mice (Fig. 2 and 3)
is mainly responsible for the reduction in iNOS expression in these
mice.
IRF-5 is upregulated in T-cells during L. donovani
infection
Since IRF-5 seems to be involved in the maintenance of the
inflammatory response to L. donovani and in the development of
protective Th1-responses, we were interested in which cells IRF-5
expression is essential for displaying and/or inducing anti-
leishmanial effector function. Thus, we analyzed the cell-specific
expression pattern of IRF-5 mRNA in the liver and the spleen at
different time points during infection (Fig. 6). Interestingly, in the
spleen IRF-5 mRNA was only upregulated in the CD5
+
population, corresponding to T-cells. The increase in IRF-5
mRNA levels was only detected at d28 p.i. (Fig. 6A). Splenic B-
cells, macrophages, dendritic cells, and neutrophils did not show
increased expression of IRF-5 mRNA at any time point analyzed
(data not shown). In the liver, only the CD5 positive fraction (T-
cells) had upregulated IRF-5 mRNA at d14 p.i. (Fig. 6B). However
by d28 p.i., only few T-cells were present in the liver (Fig. 2 and 3)
and at this time point T-cells did not express IRF-5 mRNA at
levels greater than in naı ¨ve mice.
TLR7 is essential for the development of host protective
Th1 responses
We and others have previously shown that IRF-5 can be
activated by TLR7 [16] and TLR9 [13] via the MyD88 signaling
pathway. Indeed, it was recently shown that Leishmania infections
in Tlr9
-/- mice induced transiently deficient Th1 responses [7,9],
suggesting that the regulation of these responses in Leishmania
infections might also be governed by other pathogen recognition
pathways. Thus, we next investigated which TLR was involved in
the activation of IRF-5 and consequently in the modulation of Th1
responses following L. donovani infection.
Hence we proceeded to assess whether TLR7 was involved in
the recognition of L. donovani and in the generation of parasite-
specific Th1 responses. To our surprise, L. donovani infection in
Tlr7
-/- mice resulted in a approximately 3-fold higher hepatic
parasite burden at day 28pi compared to WT mice (Fig. 7A); as
seen in Irf5
-/- mice, the splenic parasite burden in Tlr7
-/- mice was
similar to the WT control group (data not shown). These results
suggest that TLR7 plays a role in the recognition of L. donovani
Figure 6. IRF-5 is upregulated in T-cells during L. donovani
infection. Real time PCR analysis of spleens (A) and livers (B) from
infected WT mice measuring mRNA for IRF-5. All data is presented as
the mean 6 SEM combined from two independent experiments, n=6
mice per group.
doi:10.1371/journal.ppat.1001246.g006
Figure 7. TLR7 activation is essential for the development of
Th1 responses following L. donovani infection. (A) The hepatic
parasite burden was determined for infected WT and Tlr7
-/- mice at d14
and d28 pi as described. (B) The percentage of CD4
+ T cells producing
IFNc as a response to L. donovani infection in the liver of WT and Tlr7
-/-
mice was determined by intracellular flow cytometry. (C) Percentage of
IFNc
+ CD4
+ T-cells in the liver and (D) the spleen of WT and Irf7
-/- mice.
(E,F) Real time PCR analysis of spleens (E) and livers (F) from infected WT
and Irf7
-/- mice measuring mRNA for IRF5. Data is shown as the mean 6
SEM. Data is representative of two independent experiments.
doi:10.1371/journal.ppat.1001246.g007
Role of IRF5 in the Immunity to Leishmania
PLoS Pathogens | www.plospathogens.org 6 January 2011 | Volume 7 | Issue 1 | e1001246parasites and in the generation of protective immune responses
against Leishmania.
We then determined the frequency of IFNc
+ CD4
+ T-cells in
infected Tlr7
-/- mice and WT controls. At day 14 p.i the frequency
of IFNc producing CD4
+ T-cells was similar in the liver of Tlr7
-/-
mice compared to the WT control group. However, at day 28,
only 6.4% of CD4
+ T-cells in the liver of Tlr7
-/- mice was
producing IFNc compared to 14.5% in WT mice (Fig. 7B and S3).
A similar reduction in IFNc production was observed in the spleen
(data not shown). Interestingly, the extent of the inflammatory cell
infiltration in the livers of Tlr7
-/- mice at day 28 p.i. was
comparable to WT mice (data not shown). Taken together, these
results suggest that the activation of TLR7 is crucial for the
development of Th1 responses following L. donovani infection.
Since TLR7 not only signals through IRF5 but also through
IRF7 [31] and IRF7 has recently been shown to regulate killing of
intracellular Leishmania in marginal zone macrophages [32], we
wanted to determine whether IRF7 contributed to the defect in
Th1 responses we observed in Tlr7
-/- mice. Hence, we infected
Irf7
-/- mice with L. donovani amastigotes and compared the
development of Th1 responses in these mice to infected WT
controls. The results revealed that in Irf7
-/- mice, L. donovani
induced IFNc-producing CD4
+ T-cells at frequencies comparable
to infected WT mice (Fig. 7C and D).
Finally, we compared the cell-specific IRF-5 mRNA expression
pattern in WT and Tlr7
-/- mice at d14 and d28 p.i.. As previously
shown (Fig. 6), only the CD5
+ fraction (T-cells) had upregulated
IRF-5 mRNA in the spleen of infected WT mice (Fig. 7E). The
IRF-5 mRNA expression was not significantly higher in B-cells
and non-B/non-T-cells from infected WT mice compared to the
corresponding naı ¨ve WT cell populations (data not shown).
Interestingly, we could not detect any upregulation of IRF-5
mRNA expression in splenic T-cells from infected Tlr7
-/- mice at
d28 p.i., suggesting that TLR7 is essential for the induction of IRF-
5 in T-cells in the spleen at later stages of infection. In contrast, in
the liver, IRF-5 mRNA expression was only upregulated in T-cells
purified at day 14 p.i. from infected WT and Tlr7
-/- mice (Fig. 7F).
This suggests that increased IRF-5 expression in T-cells is
independent of TLR7 during the early stages of infection in the
liver. No IRF-5 mRNA could be detected at d28 p.i. in the liver of
WT and Tlr7
-/- mice (Fig. 7F).
Taken together, these data suggest that IRF-5 is a key molecular
switch for the development of Th1 responses following L. donovani
infection, and that TLR7-mediated IRF-5 activation plays a
critical role during chronic infection.
Discussion
In the present study we have demonstrated that the TLR7-
mediated activation of IRF-5 is required for the development of
host-protective Th1 responses to L. donovani at later stages of
infection. Moreover, IRF-5 deficiency resulted in an IL-4
dominated response, reduced iNOS expression, and failure to
control parasite growth in the liver. To our knowledge, the role of
IRF-5 in modulating adaptive T-cell responses is a novel and
previously undescribed finding.
One of the key points in the induction of a protective immunity
to Leishmania parasites is the generation of IFNc-producing CD4
+
T-cells. Although IL-12 production by DC is crucial for the
development of Th1 cells [25], the mechanism leading to the
generation of these responses remains elusive. A study in Myd88
-/-
mice infected with Leishmania has highlighted the importance of
TLRs, IL-1 and/or IL-18 in the induction of IL-12 and the
generation of Th1 responses. Indeed, MyD88 deficiency resulted
in complete abrogation of IFNc production by CD4
+ T-cells and
an inability to control infection [5]. More recently, TLR9
activation was shown to play a crucial role in the induction of
IL-12 secretion by DCs following T. cruzi and/or Leishmania
infections [6,7]. However, unlike T. cruzi infections, attenuation of
Th1 responses to Leishmania infection in Tlr9
-/- mice was only
transient [7,9]. These studies suggest that the regulation of Th1
responses in Leishmania infections is not exclusively mediated by
TLR9 and might be governed by other pathogen recognition
pathways as well. Our study pinpoints IRF-5, a transcription
factor in the MyD88-mediated TLR pathways, as an essential
factor in the development of adaptive Th1 responses following
Leishmania infection. Interestingly, while Th1 responses in Irf5
-/-
mice were severely impaired 4 weeks after infection, expression of
IRF-5 was not required during the first 2 weeks of infection, since
the frequency of IFNc-producing CD4
+ T-cells in Irf5
-/- mice was
comparable to WT mice. This observation suggests that IRF-5 is
not essential for the early induction of Th1 responses but is crucial
for their further development and expansion. Although IRF-5 has
been shown to have a major impact on the innate immune
response to viral infections [17,18], its role in shaping the
development of adaptive Th1 responses has not been previously
demonstrated.
Defective Th1 responses were also observed in Tlr7
-/- mice
infected with L. donovani. IRF-5 and IRF-7 are both known to be
activated by the MyD88-dependant TLR7 signaling pathway
[16,31], however IRF-7 deficiency did not result in defective Th1
responses to L. donovani. TLR7 has been shown to recognize single-
stranded RNA [33,34] and to play an essential role in the
immunity to ssRNA virus [24,35]. Recognition of a DNA virus,
the murine cytomegalovirus, by TLR7 has also been reported
[36]. To date there is no indication of TLR7 activation by
parasites.
The analysis of cell-specific IRF-5 mRNA expression pattern
revealed that the only cells that upregulated IRF-5 during L.
donovani infection at d14 and 28 p.i. were T-cells. This does not
exclude, though, that other cell types such as DCs and
macrophages may express IRF5 during earlier stages of infection.
Nevertheless, IRF-5 expression in T-cells differed between the
liver and the spleen: in the liver IRF5 expression is upregulated
during the first 2 weeks of infection in a TLR7-independent
manner; in contrast, in the spleen the upregulation occurs 4 weeks
into the infection and appears to be mediated by TLR7. Since the
defect in the Th1 responses seems to mainly affect the hepatic
infection, at least until d28 p.i., and IRF-5 only appears to be
upregulated in T-cells in the spleen during chronic infection, it is
tempting to speculate that effector Th1 cells generated in the
spleen are required for controlling parasite growth in the liver.
Future experiments involving splenectomized mice should be able
to prove this hypothesis.
It is possible that the upregulation of IRF-5 in T-cells may be
required depending on the subsets and activation status of the
cells. A role for IRF-5 in T-cells is yet unknown. Whether IRF-5
expression by T-cells is directly mediated by TLR 7/9 triggering
or indirectly induced by Type I IFN, produced by APC following
TLR7/9 signaling, is still an open question. Recent studies have
highlighted a role for MyD88 in T-cells [37,38], supporting the
possibility of a direct TLR7/9 –mediated IRF-5 induction. Mice
with MyD88 deficient T-cells only develop defective Th1
responses in a Toxoplasma gondii model [37], suggesting that
MyD88 signaling in T-cells is essential for Th1 cell development.
Human T-cells purified from HIV [39] and from Hepatitis C [40]
patients were also shown to express TLR7 and/or TLR9. Why
TLR7/IRF-5 activation is only required at later stages of infection
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questions that remain yet to be answered. Future investigations
will address these questions using T-cell-specific IRF-5 and TLR7
knockout mice.
Interestingly, the severe defect in Th1 responses seen in Irf5
-/-
mice affected the hepatic but did not seem to have any effect on
the splenic parasite burden, at least until day 28 p.i.. This is in
agreement with a study by Engwerda and colleagues who have
demonstrated that IL-12 neutralization did exacerbate infection in
the spleen during the first 4 weeks of infection, even though IFNc
production, which is mainly derived from CD4
+ T-cells, was
severely reduced [2]. Thus, in contrast to the liver, Th1 responses
are not critical for controlling parasite growth in the spleen during
the first 28 days of infection. These observations imply that
requirements for protection against L. donovani in the liver and in
the spleen are very distinct, and underline again the organ-specific
nature of the immune response during VL.
IRF-5 deficiency also resulted in a dramatic decrease in the
extent of the inflammatory cell infiltration in the liver at day 28
p.i.. Moreover, L. donovani failed to induce splenomegaly in Irf5
-/-
mice, which is characteristic for L. donovani infection in WT mice.
Since TLR7 deficiency did not significantly impair the recruitment
of inflammatory cells to the liver of L. donovani infected mice, we
can assume that there is some redundancy between different TLRs
recognizing different PAMPs, but commonly utilizing IRF-5 in the
induction of the inflammatory response during VL. Such
overlapping effects between TLR7 and TLR9 have been observed
during murine cytomegalovirus infection [36]. However, TLR7
and TLR9 were recently shown to have distinct effects in a murine
model of Lupus [41] and also during experimental West Nile
Encephalitis, where Tlr7
-/- mice, but not Tlr9
-/- mice, showed an
impaired CD45
+ leukocyte and macrophage infiltration at the site
of infection [24]. Failure of these cells to migrate to infected target
organs was caused by a significant reduction in IL-23 responses
[24]. In L. donovani infected Irf5
-/- mice, the level of IL-23 p19 were
slightly higher compared to WT mice, suggesting that the lack of
lymphocyte infiltration in the liver was not caused by the
decreased induction of IL-23, but by some other yet unidentified
pathways. Furthermore, the frequency of IL-17 producing cells,
which are typically induced by IL-23 [42], was comparable in both
groups of mice. This indicates that IRF-5 deficiency only affected
the development of Th1 responses, but not the generation of Th17
cells in L. donovani infected mice.
NO is an important leishmanicidal effector molecule. It has
direct microbial toxicity and it is also involved in the regulation of
cytokine gene expression and cytokine responsiveness. NO is
typically produced by classically activated macrophages upon
triggering of interferon and TLR pathways that enhance
expression of iNOS [28,29,30]. Expression of iNOS in mice
infected with L. donovani appears to be tissue-specific: this enzyme is
induced in the liver, however only limited iNOS expression is
observed in the spleen [43]. Despite defective IFNc responses in
Irf5
-/- mice the level of iNOS mRNA expression was comparable
to the WT control group. Since iNOS expression can also be
triggered by TLR pathways, high levels of iNOS mRNA in Irf5
-/-
mice may most likely be due to the high parasite burden in the
liver at d28pi. Interestingly though, iNOS protein was not detected
in the livers of Irf5
-/- mice. A possible explanation for the lack of
iNOS protein in Irf5
-/- mice is that iNOS may be competing with
arginase 1. This enzyme is commonly linked to alternative
pathway of macrophage activation [44]. However, arginase 1
can also be induced in classically activated macrophages and can
reduce NO production through competition with iNOS for their
common substrate arginine [45]. Arginase 1 was also shown in
vitro to suppress translation and enzymatic activity of iNOS
without affecting mRNA levels [46,47]. Nevertheless, arginase 1
mRNA was only slightly increased in Irf5
-/- mice compared to WT
mice, an increase that is probably not sufficient to inhibit
translation of iNOS protein. Another possible explanation is that
the severe defect in pro-inflammatory and the concomitant
increase in Th2 responses observed in Irf5
-/- mice may be
responsible for the lack of amplification of the iNOS expression.
Further investigations are needed to clarify the role of IRF-5 in the
molecular mechanisms involved in the regulation of iNOS
production.
In conclusion, we have indentified IRF-5 as a critical
component for the development of Th1 responses to Leishmania
infection. Furthermore, IRF-5 is an essential factor for the
maintenance of the inflammatory response and plays a role in
the indirect regulation of iNOS expression during L. donovani
infection. Further experiments have yet to determine the
molecular mechanism by which IRF-5 affects the development
of host protective immunity to L. donovani.
Materials and Methods
Mice and parasites
Ethics statement: All experiments were approved by and
conducted in accordance with guidelines of the Animal Care
and Use Committee of the Johns Hopkins University School of
Medicine.
C57BL/6J mice were obtained from The National Cancer
Institute (Frederick, MD, USA), and B6.129S7-Rag1
tm1Mom/J from
The Jackson Laboratory. All mice were housed in the Johns
Hopkins University animal facilities (Baltimore, MD) under
specific pathogen-free conditions and used at 6–8 weeks of age.
Irf5
-/- mice were a generous gift from Dr. T. Mak (University of
Toronto, Canada) and were backcrossed to C57BL/6J for at least
10 generations. The SNP analysis confirmed that they are 100%
C57BL/6. We have previously reported age related splenomegaly
in Irf5
-/- mice that was associated with changes in splenic
architecture [48]. The background of these mice was only 92%
C57BL/6. In this study we have used 6–8 weeks old Irf5
-/- mice
that have normal spleen size and splenic architecture. Tlr7
-/- mice
were a generous gift from Dr S. Akira (Osaka University, Japan).
Tlr7
-/-were backcrossed to C57BL/6J for 9 generations. Irf7
-/-
mice were a kind gift from Dr. T. Taniguchi (University of Tokyo,
Japan). Irf7
-/- were backcrossed to C57BL/6J for 8 generations.
Leishmania donovani (strain LV9) parasites were maintained by serial
passage in B6.129S7-Rag1
tm1Mom/J mice, and amastigotes were
isolated from the spleens of infected animals. Mice were infected
by injecting 2610
7 amastigotes intravenously via the lateral tail
vein. Hepatic and splenic parasite burdens were determined by
examining methanol-fixed, Giemsa stained tissue impression
smears. Data are presented as Leishman Donovan Units (LDU).
Flow cytometry
Mice were euthanized at indicated time points. Mononuclear cells
were purified from the liver as previously described [49]. Hepatic
mononuclear cells and splenocytes were restimulated for 2 h at 37uC
in the presence of bone marrow derived dendritic cells (BMDC)
previously pulsed with paraformaldehyde fixed amastigotes. Brefeldin
A was then added for a further 4 h. Cells were then stained with
biotinylated anti-CD3 followed by PerCP-conjugated strepatvidin,
FITC-conjugated anti-CD4, and APC-conjugated anti-IFNc (all BD
Bioscience). Flow cytometric analysis was performed with a LSRII
flow cytometer (Becton Dickinson). 350,000 cells per sample were
acquired and analyzed with the FACSDiva software.
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Spleens from infected and naive C57BL/6 mice were divided
into 2 groups. Group A: B-cells were first enriched from splenic
single cell suspension using anti-B220 beads (Miltenyi Biotec)
following manufacturer instructions. B-cells were then sorted to
.98% purity using FACSVantage (Becton Dickinson) based on
their expression of CD19 and B220. The B220 negative fraction
was then incubated with anti-CD5 beads for the enrichment of T-
cells. T-cells were then sorted to .98% purity using FACSVan-
tage based on their expression of CD4
+, CD8
+ and NK1.1
-. Group
B: splenocytes were first incubated with anti-CD11c beads and
conventional splenic DCs were then sorted to .98% purity based
on their expression of CD11c and MHCII. The CD11c negative
fraction was then incubated with anti-CD11b beads. CD11b+ cells
were sorted into different populations based on their expression of
Gr1, MHCII and CD11b.
Livers from infected and naı ¨ve C57BL/6 mice and from
infected Tlr7
-/- mice were incubated with anti-CD5 beads in order
to enrich T-cells. The purity of the T-cell preparation was .87%.
Spleens from infected WT and Tlr7
-/- mice were first incubated
with anti-B220 beads; the B220 negative fraction was then
incubated with anti-CD5 beads. .82% of the B220+ cells were B-
cells; .94% of the CD5+ cells were T-cells.
Preparation and infection of bone marrow derived
macrophages
Macrophages were differentiated from the bone marrow
following red blood cell lysis. Cells were incubated with 30 ng/
ml M-CSF (RnDSystems) for 5 days. Prior to use cells were
counted and seeded at the 5610
5 cells/well in a 24 well plate,
rested in the absence of M-CSF for several hours and then treated
with LPS (1 mg/ml) (Sigma-Aldrich) or L. donovani (MOI 10) for
1 h. Media was then changed to remove any extracellular
parasites and cells incubated in fresh media for a further 18 h.
At experimental end point supernatant was collected and cells
washed in PBS and lysed for RNA extraction.
RNA extraction and real time PCR analysis
For the analysis of the IL-12p35/IL-12p40 mRNA induction,
WT and Irf5
-/- mice were infected with 2610
7 L.donovani
amastigotes. 5 h later, mice were euthanized and CD11c
+
dendritic cells were isolated from splenic single cell suspensions
using anti-CD11c beads (Miltenyi Biotec) following manufacturer
instructions. The purity of the preparation was about 85%. RNA
was extracted using Trizol (Invitrogen) as per manufacturer’
instructions. For purified cell populations listed in the previous
section RNA was extracted using the RNEasy Mini Kit (Qiagen).
Reverse transcription was performed using the QuantiTect
Reverse Transcription kit (Qiagen). SybrGreen was used to assay
beta actin [17], IL-12p40 and IL-12p35. The following primers
were used: IL-12p35 F- CCACCCTTGCCCTCCTAAAC and
R-GGCAGCTCCCTCTTGTTGTG; IL-12p40 F- CTTGCA-
GATGAAGCCTTTGAAGA and R- GGAACGCACCTTT-
CTGGTTACA. For infected mice, livers and spleens were
collected at indicated time points and whole tissue RNA extracted
using Trizol, cDNA generated using the QuantiTect Reverse
Transcription kit. Other than IL-12p35 and IL-12/23p40 all gene
expression was analyzed using Taqman primers with a StepOne-
Plus cycler (Applied Biosystems).
NO quantiation
Nitric oxide was quantitated using the Greiss assay (Promega)
according to manufacturer’s instructions.
Immunohistochemistry
For frozen sections, livers from infected mice and uninfected controls
were embedded in OCT (TissueTek), snap frozen and 5 mms e c t i o n s
cut. Sections were stained for iNOS/NOS2 using an anti-iNOS
polyclonal antibody generated in rabbit (Chemicon/Millipore) and
detected using anti-rabbit IgG conjugated to HRP and DAB substrate
(both Vector Laboratories). Paraffin-embedded sections were prepared
from liver fixed in neutral buffered formalin, cut to 5 mm and stained
by H&E. All immunohistochemistry was analyzed by light microscopy
and photographs taken at the indicated magnifications.
Luciferase assay
HEK293 cells were seeded at 1610
5 cells/well in 96 well plates.
Cells were transfected with the NOS2-luc reporter construct (50 ng)
(Addgene) and Renilla luciferase (10 ng) with either MyD88 (50 ng)
and/or murine IRF-5 (100 ng) expression plasmids. 24 hours after
transfection cells were lysed and assayed for luciferase activity using
the Promega Dual-luciferase reporter assay. Luciferase activity was
normalized against Renilla. Data shown is the mean6 SEM for
triplicate samples from 2 independent experiments.
Statistical analysis
Results were analyzed using an unpaired Student t-test. P,0.05
was considered significant. Real time PCR results were analyzed
using an unpaired Student t-test or the Mann-Whitney test. For
bone marrow derived macrophages the non parametric t-test with
Welch’s correction was used. P,0.05 was considered significant.
Experiments were repeated at least twice.
Supporting Information
Figure S1 (A) The percentage of Gr1
hi CD11b
hi MHCII
- cells
(neutrophils) in the spleen of WT and Irf5
-/- mice at day 14 and 28
p.i. was determined by flow cytometry. Data is shown as the mean
6 SEM. Flow cytometry data is representative of two independent
experiments. * denotes p,0.05. (B) Representative sections of
H&E stained, paraffin-embedded spleens from WT and Irf5
-/-
mice. Pictures were taken at indicated magnifications and show
the presence of a large neutrophil infiltrate in the spleen of d28
infected Irf5
-/- mice as indicated by arrows.
Found at: doi:10.1371/journal.ppat.1001246.s001 (7.54 MB TIF)
Figure S2 Bone marrow derived macrophages were incubated
in vitro with L. donovani (MOI 10) or LPS (1 mg/ml) for 18 h. (A)
Nitric oxide production in the culture supernatant measured by
Griess assay. (B) Real time PCR analysis measuring mRNA for IL-
6, TNFa, and IFNb. All data is presented as the mean 6 SEM.
Found at: doi:10.1371/journal.ppat.1001246.s002 (0.18 MB TIF)
Figure S3 Representative scatter plots from WT and Tlr7
-/-
mice infected with L. donovani showing IFNc production by CD4
+
T cells in the liver at different times post infection. Plots are
representative of 2 independent experiments.
Found at: doi:10.1371/journal.ppat.1001246.s003 (0.22 MB TIF)
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